Stocks:
5,167
ETFs:
2,288
Exchanges:
11
Market Cap:
$62.22T
24h Vol:
$8.12B
Dominance:
MSFT:4.87%
Stocklytics Platform
Instrument logo  NARI
Inari Medical
NARI
58 / 100
$37.11arrow_drop_down2.16%-$0.82

Performance History

Stocklytics logo
Key Stats
Open$37.95
Prev. Close$37.93
EPS-0.03
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$2.19B
PE Ratio-
LOWHIGH
Day Range36.81
38.36
52 Week Range36.73
71.85
Ratios
P/B Ratio5.08
Revenue$493.63M
Operating M. %0.84%
Earnings$0.00
Earnings Growth %94.41%
EBITDA Margin %0.40%
ROE %-0.37%
EPS-0.03

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

58vs 54. Market Avg.

All Score 58 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

NARIMARKET
Value4240
Quality6440
Ownership017
Growth4047
Dividends-38
check_circle

Inari Medical 's Price discount from 1 year high of 47.1% is great compared to market average of 19.17%. This indicates NARI could be a good value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$745.69
24H (%)arrow_drop_up1.96%
24H ($)$14.35
MARKET CAP$695.32B
PRICE$486.17
24H (%)arrow_drop_down1.02%
24H ($)-$5.05
MARKET CAP$452.88B
PRICE$149.56
24H (%)arrow_drop_up0.29%
24H ($)$0.44
MARKET CAP$359.34B
PRICE$126.88
24H (%)arrow_drop_down0.04%
24H ($)-$0.06
MARKET CAP$321.54B

About Inari Medical (NARI)

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Andrew J. Hykes
Headquarters
Irvine
Employees
1100
Exchange
NASDAQ
add Inari Medical  to watchlist

Keep an eye on Inari Medical

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Inari Medical 's (NARI) price per share?

The current price per share for Inari Medical (NARI) is $37.11. The stock has seen a price change of -$0.82 recently, indicating a -2.16% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Inari Medical (NARI)?

For Inari Medical (NARI), the 52-week high is $71.85, which is 93.61% from the current price. The 52-week low is $36.73, the current price is 1.03% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Inari Medical (NARI) a growth stock?

Inari Medical (NARI) has shown an average price growth of -28.4% over the past three years. It has received a score of 20 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Inari Medical as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Inari Medical (NARI) stock price performance year to date (YTD)?

As of the latest data, Inari Medical (NARI) has a year-to-date price change of -43.58%. Over the past month, the stock has experienced a price change of -12.46%. Over the last three months, the change has been -34.93%. Over the past six months, the figure is -35.4%.

help
Is Inari Medical (NARI) a profitable company?

Inari Medical (NARI) has a net income of -$1.64M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 86.86% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0.84% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $493.63M, with a revenue growth rate of 28.73%, providing insight into the company's sales performance and growth. The gross profit is $428.76M. Operating income is noted at -$3.63M. Furthermore, the EBITDA is $15.18M.

help
What is the market capitalization of Inari Medical (NARI)?

Inari Medical (NARI) has a market capitalization of $2.2B. The average daily trading volume is 923.31K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.